NDA 214235 describes ARGATROBAN, which is a drug marketed by
Amneal Pharms Co,
Caplin,
Endo Operations,
Fresenius Kabi Usa,
Gland Pharma Ltd,
Hikma Pharm Co Ltd,
Hospira,
Mylan Institutional,
Sandoz,
Teva Pharms Usa,
Cipla,
Accord Hlthcare, and
Eugia Pharma Speclts, and is included in sixteen NDAs. It is available from
nine suppliers. There are two patents protecting this drug and two Paragraph IV challenges. Additional details are available on the
ARGATROBAN profile page.
The generic ingredient in ARGATROBAN is
argatroban. There are eleven
drug master file entries for this compound. Eleven
suppliers are listed for this compound. Additional details are available on the
argatroban profile page.